BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18193393)

  • 1. Tyrosine kinase expression in pediatric high grade astrocytoma.
    Liang ML; Ma J; Ho M; Solomon L; Bouffet E; Rutka JT; Hawkins C
    J Neurooncol; 2008 May; 87(3):247-53. PubMed ID: 18193393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.
    Thorarinsdottir HK; Santi M; McCarter R; Rushing EJ; Cornelison R; Jales A; MacDonald TJ
    Clin Cancer Res; 2008 Jun; 14(11):3386-94. PubMed ID: 18519768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR.
    Schirosi L; Lantuejoul S; Cavazza A; Murer B; Yves Brichon P; Migaldi M; Sartori G; Sgambato A; Rossi G
    Am J Surg Pathol; 2008 Nov; 32(11):1627-42. PubMed ID: 18753943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-13 receptor alpha 2 as a marker of poorer prognosis in high-grade astrocytomas.
    Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Otsuka Y; Yamaguchi M; Ohnishi H; Ohtaki S; Noshiro S; Ookawa S; Mikami T; Mikuni N; Honmou O
    J Neurosurg Sci; 2018 Jun; 62(3):239-244. PubMed ID: 28079349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH1 expression is correlated with pathologic grade and poor clinical outcome in patients with astrocytoma.
    Liu DY; Ren CP; Yuan XR; Zhang LH; Liu J; Liu Q; Yuan J; Yuan D; Jiang XJ
    J Clin Neurosci; 2012 Dec; 19(12):1700-5. PubMed ID: 23084350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt/protein kinase B overexpression as an accurate prognostic marker in adult diffuse astrocytoma.
    Matsutani T; Nagai Y; Mine S; Murai H; Saeki N; Iwadate Y
    Acta Neurochir (Wien); 2009 Mar; 151(3):263-8; discussion 268. PubMed ID: 19240976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and response of newly developed high-grade glioma cultures to the tyrosine kinase inhibitors, erlotinib, gefitinib and imatinib.
    Kinsella P; Howley R; Doolan P; Clarke C; Madden SF; Clynes M; Farrell M; Amberger-Murphy V
    Exp Cell Res; 2012 Mar; 318(5):641-52. PubMed ID: 22285130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling.
    Khatua S; Peterson KM; Brown KM; Lawlor C; Santi MR; LaFleur B; Dressman D; Stephan DA; MacDonald TJ
    Cancer Res; 2003 Apr; 63(8):1865-70. PubMed ID: 12702575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor IA is expressed in astrocytomas and is associated with improved survival.
    Song HR; Gonzalez-Gomez I; Suh GS; Commins DL; Sposto R; Gilles FH; Deneen B; Erdreich-Epstein A
    Neuro Oncol; 2010 Feb; 12(2):122-32. PubMed ID: 20150379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of chromosomal imbalances by comparative genomic hybridization and expression of EGFR, PTEN, p53, and MIB-1 in diffuse gliomas.
    Yakut T; Gutenberg A; Bekar A; Egeli U; Gunawan B; Ercan I; Tolunay S; Doygun M; Schulten HJ
    Oncol Rep; 2007 May; 17(5):1037-43. PubMed ID: 17390041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.
    Raffel C; Frederick L; O'Fallon JR; Atherton-Skaff P; Perry A; Jenkins RB; James CD
    Clin Cancer Res; 1999 Dec; 5(12):4085-90. PubMed ID: 10632344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital.
    Gajjar A; Sanford RA; Heideman R; Jenkins JJ; Walter A; Li Y; Langston JW; Muhlbauer M; Boyett JM; Kun LE
    J Clin Oncol; 1997 Aug; 15(8):2792-9. PubMed ID: 9256121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.
    Mizoguchi M; Betensky RA; Batchelor TT; Bernay DC; Louis DN; Nutt CL
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1181-8. PubMed ID: 17146292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
    Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
    Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric glioblastomas: a histopathological and molecular genetic study.
    Suri V; Das P; Pathak P; Jain A; Sharma MC; Borkar SA; Suri A; Gupta D; Sarkar C
    Neuro Oncol; 2009 Jun; 11(3):274-80. PubMed ID: 18981259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
    Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
    J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin B receptor expression in human astrocytoma: association with clinicopathological variables and survival outcomes.
    Shen C; Yang L; Yuan X
    Int J Neurosci; 2011 Nov; 121(11):626-31. PubMed ID: 21770857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.